Literature DB >> 12242128

Modulation of radiation-induced tumour necrosis factor alpha (TNF-alpha) expression in the lung tissue by pentoxifylline.

Claudia E Rübe1, Falk Wilfert, Daniela Uthe, Kurt W Schmid, Reinhild Knoop, Norman Willich, Andreas Schuck, Christian Rübe.   

Abstract

PURPOSE: The lung is the major dose-limiting organ for radiotherapy of cancer in the thoracic region. Immediate cellular damage after irradiation is supposed to result in cytokine-mediated multicellular interactions with induction and progression of inflammatory and fibrotic tissue reactions. Pentoxifylline (PTX) down-regulates the production of proinflammatory cytokines, particularly TNF-alpha, in response to noxious stimuli and may therefore provide protection against radiation-induced, cytokine-mediated cellular damage. The purpose of this study was to investigate the temporal and spatial release of TNF-alpha in the lung tissue after thoracic irradiation with 12Gy. In addition, we evaluated the ability of PTX to reduce the radiation-induced TNF-alpha release in this animal model of thoracic irradiation.
MATERIALS AND METHODS: C57BL/6J mice were exposed to either sham irradiation or single fraction of 12Gy delivered to the thorax. Four study groups were defined: those that received neither irradiation nor PTX (NT group), those that received PTX but no irradiation (PTX group), those that underwent irradiation without PTX (XRT group) and those that received both PTX and irradiation (PTX/XRT group). Treated and sham-irradiated mice were sacrificed corresponding to the latent period and the pneumonic phase. The TNF-alpha mRNA expression in the lung tissue was quantified by 'real-time' quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Immunohistochemical detection methods (alkaline phosphatase anti-alkaline phosphatase (APAAP)) and automated image analysis were used for objective quantification of TNF-alpha protein expression.
RESULTS: Following thoracic irradiation with a single dose of 12Gy (XRT group), radiation-induced TNF-alpha mRNA release in the lung tissue was significantly increased during the acute phase of pneumonitis (P<0.05). The elevated levels of TNF-alpha mRNA during the pneumonic phase correlate with a significant increase of positive inflammatory cells, predominantly macrophages, in the lung parenchyma (P<0.05). In contrast to the radiation-only group (XRT-group), the lung tissue of the PTX-treated mice (PTX/XRT group) revealed only a minor radiation-mediated TNF-alpha response on mRNA and protein level.
CONCLUSIONS: This study demonstrates a significant radiation-induced increase of TNF-alpha (on mRNA and protein level) in the lung tissue during the pneumonic phase. The predominant localisation of TNF-alpha in areas of inflammatory cell infiltrates suggests involvement of this cytokine in the pathogenesis of radiation-induced lung injury. In addition, we observed a pronounced reduction of the TNF-alpha mRNA and protein production in the study group that received both PTX and radiation (PTX/XRT group) as compared to the radiation-only group (XRT group). Therefore our results indicate that PTX down-regulates the TNF-alpha mRNA and protein production in the lung tissue in response to radiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12242128     DOI: 10.1016/s0167-8140(02)00077-4

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  39 in total

1.  Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy.

Authors:  Xin Shelley Wang; Qiuling Shi; Loretta A Williams; Li Mao; Charles S Cleeland; Ritsuko R Komaki; Gary M Mobley; Zhongxing Liao
Journal:  Brain Behav Immun       Date:  2010-03-29       Impact factor: 7.217

2.  Investigations into the role of inflammation in normal tissue response to irradiation.

Authors:  Richard Peter Hill; Asif Zaidi; Javed Mahmood; Salomeh Jelveh
Journal:  Radiother Oncol       Date:  2011-07-02       Impact factor: 6.280

3.  MyD88 provides a protective role in long-term radiation-induced lung injury.

Authors:  Willie J Brickey; Isabel P Neuringer; William Walton; Xiaoyang Hua; Ellis Y Wang; Sushmita Jha; Gregory D Sempowski; Xuebin Yang; Suzanne L Kirby; Stephen L Tilley; Jenny P-Y Ting
Journal:  Int J Radiat Biol       Date:  2012-02-06       Impact factor: 2.694

4.  Oral administration of melatonin modulates the expression of tumor necrosis factor-α (TNF-α) gene in irradiated rat cervical spinal cord.

Authors:  Gholam Hassan Haddadi; Reza Fardid
Journal:  Rep Pract Oncol Radiother       Date:  2015-02-21

5.  [Plantar fasciitis and radiotherapy. Clinical and radiobiological treatment results].

Authors:  O Micke; M H Seeegenschmiedt; R Mücke; A de Vries; U Schäfer; N Willich
Journal:  Orthopade       Date:  2005-06       Impact factor: 1.087

6.  Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer.

Authors:  Cem H Misirlioglu; Taciser Demirkasimoglu; Bulent Kucukplakci; Ergun Sanri; Kadri Altundag
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

7.  Steroid-Loaded Hemostatic Nanoparticles Combat Lung Injury after Blast Trauma.

Authors:  William B Hubbard; Margaret M Lashof-Sullivan; Erin B Lavik; Pamela J VandeVord
Journal:  ACS Macro Lett       Date:  2015-03-23       Impact factor: 6.903

8.  Preventive effect of pentoxifylline on acute radiation damage via antioxidant and anti-inflammatory pathways.

Authors:  Gülçin Hepgül; Sevda Tanrikulu; Haluk Recai Unalp; Taner Akguner; Yeşim Erbil; Vakur Olgaç; Evin Ademoğlu
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

9.  The effect of pentoxifylline on radiobiological parameters in the rat radiation myelopathy.

Authors:  Won Dong Kim; Woo Yoon Park
Journal:  Cancer Res Treat       Date:  2006-12-31       Impact factor: 4.679

10.  TNF-alpha regulates the effects of irradiation in the mouse bone marrow microenvironment.

Authors:  Ana Sofia Cachaço; Tânia Carvalho; Ana Cristina Santos; Cátia Igreja; Rita Fragoso; Catarina Osório; Manuela Ferreira; Jacinta Serpa; Sofia Correia; Perpétua Pinto-do-O; Sérgio Dias
Journal:  PLoS One       Date:  2010-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.